SCIRENT works with biopharmaceutical and medical technology companies across all phases of development. As a specialty full-service contract research organization, we offer industry-leading solutions across a wide range of chronic and acute cardiovascular indications.
SCIRENT helps customers to translate science into new treatments by offering strong scientific and medical expertise and deep therapeutic insights. We offer tailored services across all phases of development, from early protocol development consulting through regulatory submissions, clinical conduct, and reporting.
Our experienced team of clinical research professionals assists you in designing, conducting, and monitoring clinical trials. Our main differentiator is our focus on cardiovascular disease and the ability to provide you with strengths from academic research and efficiencies from a commercial organizational structure.
SCIRENT offers extensive expertise to support early-phase studies. Our multi-disciplinary experts help you transition your data from pre-clinical to human research with highly tailored models for FIH research through Proof of Concept as fast as possible with informed and timely decision-making.
Read our case studies to learn more about our focus on early clinical trials
SCIRENT has executed numerous medical device studies across all development phases and post-marketing. Our operational model aligns with the latest industry regulations and maintains strong relationships with recognized groups for in-depth regulatory guidance. We offer consulting and clinical execution services in more than 15 countries in Europe for EFS, CE-mark trials, pivotal and post-market trials.
Read our case studies to learn more about our focus on medical device trials
Cardiovascular studies are complex and require unique know-how, so we only work with specialized research sites with long-term experience in conducting cardiovascular trials. In addition, we also maintain close relationships with highly experienced Investigators that drive quality results and effective Patient recruitment. Our specialized site network spans across Europe and North America.
of our trials are cardiovascular trials with heart failure being the main focus of all indications
of the trials we conduct are medical device trials, making us a strong partner for medical device innovation
reduced start-up times due to excellent personal contacts with trial sites, and engaged investigators
is the average time of research experience our investigators have in conducting clinical trials
How can we help you? We will get in touch shortly.
